NPPA issued a notification regarding fixation of retail price of Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg

Jul 08, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 04, 2024, issued a notification regarding the fixation of the retail price of Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP (As sustained release form) 500.

The following has been stated: -

•For each Film-coated tablet contains: Sitagliptin phosphate monohydrate IP eq. to Sitagliptin 100 mg + Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP (As sustained release form) 500 mg for M/s Akums Drugs & Pharmaceuticals Ltd (Manufacturer) and M/s Aristo Pharmaceuticals Private Limited (Marketer) the retail price is 14.00.

The detailed notification is given in the document attached below.

[Notification No. 19(4084)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT